Agnieszka Kulczyńska-Przybik Selected Research

Chemokine CX3CL1

1/2020

Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agnieszka Kulczyńska-Przybik Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2015
7	Dementia (Dementias) 08/2023 - 01/2017
7	Cognitive Dysfunction 08/2023 - 01/2020
6	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 03/2020
5	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2023 - 01/2018
4	Multiple Sclerosis 02/2024 - 08/2018
4	Inflammation (Inflammations) 07/2023 - 03/2020
2	Relapsing-Remitting Multiple Sclerosis 02/2024 - 01/2023
2	COVID-19 02/2024 - 01/2023
2	Infections 02/2024 - 01/2023
2	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 01/2018
2	Neoplasms (Cancer) 03/2020 - 01/2020
2	Neuroinflammatory Diseases 01/2020 - 01/2017
1	Thyroid Diseases (Thyroid Disease) 03/2024
1	Hemolysis 11/2023
1	Obstructive Sleep Apnea 09/2023
1	Melanoma (Melanoma, Malignant) 07/2023
1	Lymphatic Metastasis 07/2023
1	Disease Progression 01/2022
1	Stomach Neoplasms (Stomach Cancer) 10/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2018
1	Nervous System Diseases (Neurological Disorders) 08/2018
1	Central Nervous System Diseases (CNS Diseases) 08/2018
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 08/2018
1	Esophageal Neoplasms (Esophageal Cancer) 10/2016

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2017
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2018
6	Tumor Biomarkers (Tumor Markers)IBA 07/2023 - 01/2018
5	C-Reactive ProteinIBA 07/2023 - 01/2018
5	ChemokinesIBA 03/2022 - 01/2020
4	Carcinoembryonic AntigenIBA 07/2023 - 03/2020
3	Interleukin-8 (Interleukin 8)IBA 09/2023 - 10/2016
3	NeurograninIBA 08/2023 - 11/2020
2	MicroRNAs (MicroRNA)IBA 03/2024 - 11/2023
2	AntibodiesIBA 02/2024 - 01/2023
2	Amyloid (Amyloid Fibrils)IBA 08/2023 - 07/2023
2	LigandsIBA 03/2022 - 01/2020
2	diazonaphthalenedisulfonic acid (NDS)IBA 11/2021 - 01/2018
2	Interleukin-8B ReceptorsIBA 10/2021 - 01/2018
1	Immunoglobulin G (IgG)IBA 02/2024
1	Neutralizing AntibodiesIBA 02/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 09/2023
1	Interleukin-10 (Interleukin 10)IBA 09/2023
1	IgA receptor (protein B)IBA 07/2023
1	Glycoproteins (Glycoprotein)IBA 07/2023
1	Peptides (Polypeptides)IBA 07/2023
1	Indicators and Reagents (Reagents)IBA 07/2023
1	VaccinesIBA 01/2023
1	Interferon-betaIBA 01/2023
1	Glatiramer Acetate (Copaxone)FDA Link 01/2023
1	AntigensIBA 01/2023
1	Dimethyl FumarateIBA 01/2023
1	CC ChemokinesIBA 03/2022
1	neuronal pentraxin receptorIBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2021
1	Fatty Acid-Binding ProteinsIBA 07/2021
1	Apolipoprotein E4IBA 07/2021
1	Fatty Acid Binding Protein 3IBA 07/2021
1	LipidsIBA 07/2021
1	NeurocalcinIBA 11/2020
1	Chemokine CX3CL1IBA 01/2020
1	Vitamin D-Binding ProteinIBA 08/2018
1	EnzymesIBA 08/2018
1	ImmunosorbentsIBA 08/2018
1	tau Proteins (tau Protein)IBA 01/2017
1	Amyloid beta-PeptidesIBA 01/2017
1	CalciumIBA 01/2015
1	visininIBA 01/2015

Therapy/Procedure

3	Therapeutics 02/2024 - 07/2022
1	Immunomodulation 02/2024